↓ Skip to main content

Response to sorafenib treatment in advanced metastatic thyroid cancer

Overview of attention for article published in Arquivos Brasileiros de Endocrinologia & Metabologia, February 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Response to sorafenib treatment in advanced metastatic thyroid cancer
Published in
Arquivos Brasileiros de Endocrinologia & Metabologia, February 2014
DOI 10.1590/0004-2730000002839
Pubmed ID
Authors

Fabian Pitoia

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 July 2020.
All research outputs
#15,473,755
of 22,994,508 outputs
Outputs from Arquivos Brasileiros de Endocrinologia & Metabologia
#202
of 481 outputs
Outputs of similar age
#191,322
of 308,643 outputs
Outputs of similar age from Arquivos Brasileiros de Endocrinologia & Metabologia
#6
of 15 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 481 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,643 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.